800-P: Phase 3 Results of Fixed-Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients

BRIJ MOHAN; MANOJ S. CHAWLA; RAHUL R. KODGULE; MONIKA TANDON; SAGAR KATARE; SACHIN SURYAWANSHI; HANMANT V. BARKATE

doi:10.2337/db21-800-p

800-P: Phase 3 Results of Fixed-Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients

Diabetes ◽

10.2337/db21-800-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 800-P

Author(s):

BRIJ MOHAN ◽

MANOJ S. CHAWLA ◽

RAHUL R. KODGULE ◽

MONIKA TANDON ◽

SAGAR KATARE ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Phase 3 ◽

Dose Combination ◽

Remogliflozin Etabonate

Download Full-text

Phase 3 randomized, controlled clinical trial of bictegravir coformulated with FTC/TAF in a fixed-dose combination (B/F/TAF) vs dolutegravir (DTG) + F/TAF in treatment-naïve HIV-1 positive adults: week 48 results

10.26226/morressier.5aeaf2d35800a00019097f85 ◽

2018 ◽

Author(s):

Christian Wisskirchen ◽

Hans-Jürgen Stellbrink

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725431366.793505980 ◽

2015 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Genotype 1 ◽

Open Label ◽

Phase 3 ◽

Treatment Naïve ◽

Dose Combination ◽

Previously Treated

Download Full-text

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

Advances in Therapy ◽

10.1007/s12325-020-01277-2 ◽

2020 ◽

Vol 37 (4) ◽

pp. 1620-1631 ◽

Cited By ~ 4

Author(s):

Sanjay Asrani ◽

Jason Bacharach ◽

Edward Holland ◽

Hayley McKee ◽

Huan Sheng ◽

...

Keyword(s):

Ocular Hypertension ◽

Open Angle Glaucoma ◽

Safety Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Angle ◽

Phase 3 ◽

Dose Combination

Download Full-text

O109 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-2 STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)60111-2 ◽

2014 ◽

Vol 60 (1) ◽

pp. S45 ◽

Cited By ~ 1

Author(s):

N. Afdhal ◽

R.K. Reddy ◽

P. Pockros ◽

A.M. Di Bisceglie ◽

S. Arora ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Genotype 1 ◽

Phase 3 ◽

Dose Combination

Download Full-text

Tu2038 All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

Gastroenterology ◽

10.1016/s0016-5085(14)63284-4 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-903 ◽

Cited By ~ 1

Author(s):

Ira M. Jacobson ◽

Patrick Marcellin ◽

Alessandra Mangia ◽

Paul Y. Kwo ◽

Graham Foster ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Genotype 1 ◽

Phase 3 ◽

Treatment Naïve ◽

Dose Combination

Download Full-text

A phase 3 randomized controlled clinical trial of bictegravir in a fixed dose combination, B/F/TAF, vs ABC/DTG/3TC in treatment-naïve adults at week 48

10.26226/morressier.5aeaf2d35800a00019097f7f ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination

Download Full-text

Phase 3 study of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting during repeated moderately emetogenic chemotherapy (MEC) cycles.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.9502 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 9502-9502 ◽

Cited By ~ 4

Author(s):

Matti S. Aapro ◽

Meinolf Karthaus ◽

Lee Steven Schwartzberg ◽

Giorgia Rossi ◽

Giada Rizzi ◽

...

Keyword(s):

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Moderately Emetogenic Chemotherapy ◽

Phase 3 ◽

Dose Combination

Download Full-text

Abstract P5-15-01: Evaluation of sustained antiemetic efficacy over repeated cycles of anthracycline-cyclophosphamide (AC)-based chemotherapy: A phase 3 study of NEPA, a fixed-dose combination of netupitant and palonosetron for prevention of chemotherapy-induced nausea and

10.1158/1538-7445.sabcs14-p5-15-01 ◽

2015 ◽

Author(s):

Matti Aapro ◽

Hope Rugo ◽

Giada Rizzi

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Phase 3 ◽

Antiemetic Efficacy ◽

Dose Combination

Download Full-text

Fixed-dose combination of nebivolol and valsartan in patients with stage 1 or 2 hypertension: ABPM substudy of a phase 3 randomized trial

Journal of the American Society of Hypertension ◽

10.1016/j.jash.2014.03.058 ◽

2014 ◽

Vol 8 (4) ◽

pp. e31

Author(s):

Thomas D. Giles ◽

George Bakris ◽

Suzanne Oparil ◽

Michael A. Weber ◽

Wei Chen ◽

...

Keyword(s):

Randomized Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Phase 3 ◽

Dose Combination ◽

Stage 1

Download Full-text

Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13491 ◽

2018 ◽

Vol 21 (1) ◽

pp. 103-111 ◽

Cited By ~ 1

Author(s):

Ji Cheol Bae ◽

Kyung Wan Min ◽

Yong Hyun Kim ◽

Kyoung-Ah Kim ◽

Eun-Gyoung Hong ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Dose Combination

Download Full-text